92 related articles for article (PubMed ID: 12771645)
41. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
42. Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
Sabatini T; Rozzini R; Trabucchi M
Circulation; 2005 May; 111(17):e276-7; author reply e276-7. PubMed ID: 15867189
[No Abstract] [Full Text] [Related]
43. Postoperative treatment with angiotensin-converting enzyme inhibitors in patients with preoperative reduced left ventricular systolic function.
Villacorta J; Oddoze C; Giorgi R; Kerbaul F; Bonnet M; Collart F; Gouin F; Guidon C
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):187-91. PubMed ID: 18375318
[TBL] [Abstract][Full Text] [Related]
44. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
Thanikachalam S; Manchanda SC
Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
46. Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy.
Didangelos TP; Arsos GA; Karamitsos DT; Athyros VG; Georga SD; Karatzas ND
J Diabetes Complications; 2006; 20(1):1-7. PubMed ID: 16389160
[TBL] [Abstract][Full Text] [Related]
47. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
[No Abstract] [Full Text] [Related]
48. Use of valsartan in post-myocardial infarction and heart failure patients.
Liu PP; Maggioni A; Velazquez EJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S19-22. PubMed ID: 16986231
[TBL] [Abstract][Full Text] [Related]
49. Valsartan an alternative to ACE inhibitor in high-risk MI.
Geriatrics; 2004 Jan; 59(1):45. PubMed ID: 14755870
[No Abstract] [Full Text] [Related]
50. Effects of intracoronary low-dose enalaprilat on ventricular repolarization dynamics after direct percutaneous intervention for acute myocardial infarction.
Bonnemeier H; Schäfer U; Kurz T; Ortak J; Hartmann F; Katus HA; Richardt G; Schunkert H
Pacing Clin Electrophysiol; 2007 May; 30(5):631-7. PubMed ID: 17461873
[TBL] [Abstract][Full Text] [Related]
51. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
Fox K; Ferrari R; Yusuf S; Borer JS
Eur Heart J; 2006 Sep; 27(18):2154-7. PubMed ID: 16905555
[TBL] [Abstract][Full Text] [Related]
52. Enalaprilat.
Dimens Crit Care Nurs; 2000; 19(2):22. PubMed ID: 10876493
[No Abstract] [Full Text] [Related]
53. Questions regarding Kostis' article on SOLVD.
Borhani NO
Am J Hypertens; 1996 Jun; 9(6):615-9. PubMed ID: 8783789
[No Abstract] [Full Text] [Related]
54. Commentary on Kostis' report from SOLVD.
Gavras I; Gavras H
Am J Hypertens; 1996 Jun; 9(6):615, 616-9. PubMed ID: 8783788
[No Abstract] [Full Text] [Related]
55. Effects of ACE inhibition on sodium excretion in COPD.
Jolobe OM
Thorax; 1995 Apr; 50(4):430. PubMed ID: 7785024
[No Abstract] [Full Text] [Related]
56. Invited commentary.
Shuhaiber J
Ann Thorac Surg; 2011 Jun; 91(6):1850-1. PubMed ID: 21619981
[No Abstract] [Full Text] [Related]
57. Commentary: Coronary revascularization in patients with left ventricular systolic dysfunction.
Huddleston SJ; Kelly RF
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1033-1034. PubMed ID: 32778463
[No Abstract] [Full Text] [Related]
58. About fACE: perioperative use of angiotensin-converting enzyme inhibitors.
Barodka V; Nyhan D; Berkowitz D
Circulation; 2012 Jul; 126(3):249-51. PubMed ID: 22715474
[No Abstract] [Full Text] [Related]
59. Commentary: Postcoronary artery bypass grafting treatment of dyslipidemia: Better hit those targets!
Ben Ali W; Perrault LP
JTCVS Open; 2022 Jun; 10():204. PubMed ID: 36004210
[No Abstract] [Full Text] [Related]
60. An ace in the hole..
Mondragon E; Maher LJ
Structure; 2012 Aug; 20(8):1285-6. PubMed ID: 22884102
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
